Two Sigma Investments’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$406K Buy
62,225
+4,838
+8% +$30.1K ﹤0.01% 3874
2025
Q4
$328K Buy
57,387
+16,742
+41% +$103K ﹤0.01% 3535
2025
Q3
$277K Buy
40,645
+23,345
+135% +$177K ﹤0.01% 3253
2025
Q2
$155K Sell
17,300
-19,036
-52% -$113K ﹤0.01% 2954
2025
Q1
$195K Buy
36,336
+11,174
+44% +$76K ﹤0.01% 2858
2024
Q4
$187K Sell
25,162
-4,831
-16% -$39.7K ﹤0.01% 2882
2024
Q3
$271K Sell
29,993
-11,062
-27% -$114K ﹤0.01% 2712
2024
Q2
$436K Sell
41,055
-46,481
-53% -$495K ﹤0.01% 2429
2024
Q1
$771K Sell
87,536
-31,579
-27% -$257K ﹤0.01% 2116
2023
Q4
$812K Buy
119,115
+23,684
+25% +$194K ﹤0.01% 2196
2023
Q3
$931K Buy
+95,431
New +$765K ﹤0.01% 1979
2022
Q1
Sell
-19,517
Closed -$118K 4338
2021
Q4
$118K Buy
+19,517
New +$120K ﹤0.01% 4036

Other funds holding ULBI

Two Sigma Investments's ULBI Position: Q1 2026 in Review

Two Sigma Investments increased its Ultralife (ULBI) stake by 8.4% in Q1 2026, buying an estimated $30.1K and bringing the position to 62,225 shares worth $406K. The position accounts for ﹤0.01% of the portfolio, ranked #3874.

Two Sigma Investments first reported a position in ULBI in Q4 2021 and has held it in 12 quarters since. The position peaked at $931K in Q3 2023. 50 funds tracked by Wall St. Rank hold ULBI as of Q1 2026.

  • Two Sigma Investments held 62,225 shares of Ultralife worth $406K as of Q1 2026.
  • Two Sigma Investments bought 4,838 Ultralife shares in Q1 2026, an estimated $30.1K.
  • Ultralife made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3874 holding.
  • Two Sigma Investments first reported a position in Ultralife in Q4 2021 and has held it in 12 quarters since.
  • Two Sigma Investments's Ultralife position peaked at $931K in Q3 2023.
  • 50 funds tracked by Wall St. Rank held Ultralife as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.